Abstract: Disclosed is a respiration-assisting tube whereby tissue damages in vivo can be prevented and, as a result, inflammatory reactions and infections can be avoided. The respiration-assisting tube is developed based on the finding that adhesion of cells to a respiration-assisting tube can be inhibited by coating the respiration-assisting tube with a polymer containing 2-methacryloyloxyethyl phosphorylcholine (MPC). Also, the respiration-assisting tube is developed based on the finding that, by coating a respiration-assisting tube with a polymer containing MPC, mucosa peeling and tissue damages, which occur after using the respiration-assisting tube, can be prevented and, as a result, inflammatory reactions can be avoided.

Abstract: [Problems] The object of the present invention is to provide a Medical Drugs which reduce damage of gastrointestinal mucosal induced by NSAIDs. [Means for Solving Problems] The Medical Drugs that comprises a mixture of NSAIDs and sugar that reduce damage of gastrointestinal mucosal induced by NSAIDs is already known. However the mixture is not enough to suppress damage of gastrointestinal mucosal. The inventors invented new molecular compounds with NSAIDs and trehalose. The new molecular compounds effectively reduce damage of gastrointestinal mucosal induced by NSAIDs.

Abstract: A method for producing an artificial bone capable of accurate molding at a joined part with appropriate strength, in which electromagnetic waves or electron beams are irradiated to a layer of at least type of powder selected from metal biomaterials, ceramics for the artificial bone and plastic resins for the artificial bone based on image data corresponding to a shape of the artificial bone, thereby effecting sintering or melting, and the thus sintered layer or melted and solidified layer is laminated, such that a surface finish step is adopted that inner faces and/or outer faces of both ends and their vicinities configuring the joined part to a human bone part are polished by a rotating tool based on the image data and also irradiation of electromagnetic waves or electron beams at both ends and their vicinities constituting the joined part is set greater than that at other regions,

Abstract: Grooves (3R, 3G, 3B) corresponding to red, green and blue respectively are formed on a substrate (40), and the edge portion of each groove (3R, 3G, 3B) is formed so as to be farther from a side of substrate (40) in order. The edge portion of each groove (3R, 3G, 3B) is immersed in an organic EL solution (8R, 8G, 8B) of corresponding color, the grooves (3R, 3G, 3B) are severally filled with the organic EL solution (8R, 8G, 8B) of corresponding color using capillary phenomenon, and thus a full-color organic EL display device is manufactured.

Abstract: Disclosed is an artificial bone material having controlled calcium ion elution, which does not induce cytotoxicity or any inflammatory response. It is found that the elution of a calcium ion from an artificial bone material for transplantation which contains a calcium-containing substance can be prevented effectively by subjecting the carrier to a surface treatment or adding a surface-treating agent to the carrier. It is also found that the induction of cytotoxicity can be prevented and the induction of an inflammatory response can also be prevented by using the above-mentioned carrier having controlled calcium ion elution.

Abstract: An object of the invention is to provide a bone filling material capable of promoting the bone regeneration effect of a growth factor such as platelet rich plasma (PRP). Inventors of the invention anticipated that the bone filling material adsorbs a growth factor like PRP, and the combined use of the bone filling material with PRP, the bone regeneration effect of PRP might be impaired. Further, the invention is basically related to the inhibition of this adsorbing effect of the bone filling material by using a capping agent. Since the adsorbing effect of the bone filling material is thus inhibited, PRP can exert the bone regeneration effect thereof in the case of using the bone filling material together with PRP.

Abstract: The objective of the invention is to provide a solution for tissue adhesion prevention and a method for tissue adhesion prevention that are applicable to general surgery and in which covering condition during surgery is stable and convenient. The invention is the solution for tissue adhesion prevention of which the active ingredient is trehalose. Also, it contains at least one or more among antioxidants, chelates, antiseptics, hemostatics, anti-inflammatory agents, and polysaccharides, mucopolysaccharides, salts of polysaccharides and salts of mucopolysaccharides having lubricating properties. This solution for tissue adhesion prevention is provided as any form of perfusion fluid, spray fluid, solution for spray or vaporization administration, foam-like aerosol preparation, injection solution for intravenous fluids, intravenous fluid.

Abstract: Laser beams emitted by a plurality of laser sources are divided into a plurality of sub-beams, which are irradiated onto selected portions of an amorphous semiconductor on a substrate to crystallize the amorphous semiconductor. A difference in diverging angles between the laser beams is corrected by a beam expander. The apparatus includes a sub-beam selective irradiating system including a sub-beam dividing assembly and a sub-beam focussing assembly. Also, the apparatus includes laser sources, a focussing optical system, and a combining optical system. A stage for supporting a substrate includes a plurality of first stage members, a second stage member disposed above the first stage members, and a third stage member 38C, rotatably disposed above the second stage to support an amorphous semiconductor.

Abstract: A liquid crystal display panel manufacturing apparatus is provided with a stage for fixing a substrate having an optical film adhered to at least one of surfaces of the substrate. The stage has a suction hole for attracting the substrate by suction. The stage has an interposition member located around a region provided with the suction hole, and the interposition member has a closed frame-like form in a plan view. A display panel manufacturing apparatus that can stably fix the substrate is provided.

Abstract: It is an object of the present invention to provide a gel-forming composition which permits on-site administration and can form a gel exhibiting prescribed strength and sustained drug release, devices for the administration thereof, and a kit for medical use. A gel-forming composition which is composed of the first composition comprising a drug, a first gelling agent represented by the general formula (I) and the like, and the first diluent and the second composition comprising the second gelling agent represented by the general formula (I) and the like and the second diluent; and application devices and kits for medical use, which can hold the gel-forming composition. X1—(OCH2CH2)n—X2 (I) wherein X1 and X2 are each —R1COONHS (wherein R1 is C1-7 alkylene), —COR1COONHS, —NOCOR1—R2 (wherein R2 is maleimido), —R1NH2, —R1SH, or —CO2PhNO2, and n is an integer of 80 to 1000.

Abstract: A DMA controller controls DMA transfer in an information processing system. Input and output devices are a transfer source or a transfer destination in DMA transfer and request DMA transfer. A DMAC activating unit is provided with an event monitoring unit and an event register. The event register registers an event subject to monitoring. The event monitoring unit detects an event generated in the input and output devices and determines whether the detected event matches an event registered in the event register. If it is determined that the events match, the event monitoring unit activates the DMA controller.

Abstract: A highly reliable liquid crystal display panel is provided in which problems such as mixing of foreign matter are prevented. A liquid crystal display panel according to the present invention includes: a composite substrate including a pair of substrates and a liquid crystal layer disposed between the pair of substrates; a microlens array provided on a light-incident side of the composite substrate; a support provided on the light-incident side of the composite substrate so as to surround the microlens array; and an optical film attached to the composite substrate via the support. The support has a protrusion protruding from an outer principal face of the support toward the external space. A venthole is formed in the support, the venthole connecting an internal space surrounded by the support and the external space. An opening of the venthole on the external space side is formed in the protrusion.

Abstract: There is provided an information processing apparatus in which a CPU and an audio processing unit are coupled by a bus. The audio processing unit includes a ring buffer that temporarily retains audio data, and performs an input/output process of the audio data. An interrupt signal generator generates a buffer empty signal, when the audio data is output from a buffer in the ring buffer and the buffer is empty, decimates the buffer empty signal in accordance with a sampling frequency of audio, and then feeds the interrupt signal that survives the decimation to the CPU. The CPU, upon receiving the buffer empty signal, issues a DMA transfer instruction for writing the audio data into the empty buffer in the ring buffer.

Abstract: When a concentration of access requests on a specific bank occurs, the delay time is caused due to the competition among the accesses, thereby lowering the processing speed of an information processing apparatus as a whole. A data transfer arbitration unit 172 sequentially transfers data to be recorded to a memory controller 160 that records data in memory having a plurality of banks. A selector 174 selects any DMAC 170 from among a plurality of DMACs, irrespective of priority sequence of transfer service for the DMAC. A transmitter 176 transmits, to a control-side transfer unit 114, data requested to be transferred by the selected DMAC 170. The selector 174 selects consecutively the DMAC 170 so that the transfer service for the same DMAC is consecutively executed, and determines the number of consecutive selections so that a transfer across the banks of the DMAC 170 occurs by a plurality of the transfer services.

Abstract: An object of the present invention is to provide an agent for treating or preventing vasospasm. An object of the present invention is to provide an agent for treating or preventing cerebral vasospasm as well as arterial vasospasm. Further, an object of the present invention is to provide an agent for treating or preventing cerebral ischemia and cerebral infarction. The above problems are solved by an agent for treating and preventing vasospasm, cerebral ischemia, or cerebral infarction, comprising trehalose as the active ingredient. It is possible, by using such a trehalose-comprising agent, to suppress phenomena such as contraction of blood vessel and thickening of tunica intima and tunica media and to prevent or treat vasospasm and vasospasm-dependent diseases.

Abstract: Laser beams emitted by a plurality of laser sources are divided into a plurality of sub-beams, which are irradiated onto selected portions of an amorphous semiconductor on a substrate to crystallize the amorphous semiconductor. A difference in diverging angles between the laser beams is corrected by a beam expander. The apparatus includes a sub-beam selective irradiating system including a sub-beam dividing assembly and a sub-beam focussing assembly. Also, the apparatus includes laser sources, a focussing optical system, and a combining optical system. A stage for supporting a substrate includes a plurality of first stage members, a second stage member disposed above the first stage members, and a third stage member 38C, rotatably disposed above the second stage to support an amorphous semiconductor.

Abstract: A one component resin composition curable with a combination of light and heat, which comprises (1) an epoxy resin, (2) an acrylic ester monomer and/or methacrylic ester monomer, or an oligomer thereof, (3) a latent epoxy curing agent, (4) a photo radical initiator, and (5) a compound having two or more thiol groups per molecule, wherein the ingredient (5) is contained in an amount of 0.001 to 5.0 parts by weight per 100 parts by weight of this resin composition. According to the present invention, a one component resin composition curable with a combination of light and heat, which has excellent curability especially in a light-shielded area can be provided. Also, a liquid crystal sealant composition curable with a combination of light and heat, which is applicable to the one-drop-fill method and has excellent curability in light-shielded areas and adhesion reliability, especially high-temperature and high-humidity adhesion reliability, can be provided.

Abstract: A bone filling material having controlled release of a pharmaceutical agent such as a growth factor, and a drug release controlling carrier having controlled release of a pharmaceutical agent is provided by inactivating a functional group which can strongly bind to the pharmaceutical agent of the bone filling material with a blocking agent. The bone filling material and the drug release controlling carrier of the present invention comprises: a calcium-based material such as hydroxyapatite, carbonate apatite, fluorapatite, chlorapatite, ?-TCP, and ?-TCP; a blocking agent of the calcium-based material such as serine and dextran; and a pharmaceutical agent.

Abstract: A secondary texture cache is used commonly by a plurality of texture units, and stores part of texture data in a main memory. A cache controlling CPU controls a refill operation from the main memory to the secondary texture cache in accordance with cache misses of the plurality of texture units, so as to suppress occurrence of thrashing in the secondary texture cache. The cache controlling CPU suppresses occurrence of the refill operation when the plurality of operating units access an identical memory address with a predetermined time difference.

Abstract: Laser beams emitted by a plurality of laser sources are divided into a plurality of sub-beams, which are irradiated onto selected portions of an amorphous semiconductor on a substrate to crystallize the amorphous semiconductor. A difference in diverging angles between the laser beams is corrected by a beam expander. The apparatus includes a sub-beam selective irradiating system including a sub-beam dividing assembly and a sub-beam focussing assembly. Also, the apparatus includes laser sources, a focussing optical system, and a combining optical system. A stage for supporting a substrate includes a plurality of first stage members, a second stage member disposed above the first stage members, and a third stage member 38C, rotatably disposed above the second stage to support an amorphous semiconductor.